Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clear-Brain in cerebral amyloid angiopathy
NL-OMON59965Phase 2Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of sodium oxybate in cerebral amyloid angiopathy (CAA) (3 arms), sponsored by Leiden University Medical Center. Started Mar 2025; status: recruiting.
02
Drugs
sodium oxybate
03
Conditions
cerebral amyloid angiopathy (CAA)
Beyond the preview
Go deeper on NL-OMON59965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59965.